Market Currents
ISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012...
-
Wednesday, January 4, 2012, 4:44 PM ETISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012 earnings and revenue to come in below estimates. It now expects its EPS to be between $0.28 - $0.39 on revenue of around $180M -$195M.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
